Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Zealand Pharma A/S
ZEALCurrent price
901 DKK
-8.94 DKK (-0.99%)
Last closed
853 DKK
Company
www.zealandpharma.com
ISIN
DK0060257814
Sector
Healthcare
Industry
Biotechnology
Exchange
Copenhagen Exchange
Capitalization
60 285 574 774 DKK
Yield for 12 month
+207.72 %
1Y
3Y
5Y
10Y
15Y
ZEAL
Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The company offers Dasiglucagon, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon that is in Phase III clinical trials for treating congenital hyperinsulinism. The company is also developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. The company was incorporated in 1997 and is based in Søborg, Denmark. Address: Sydmarken 11, Søborg, Denmark, 2860
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
6 584.61 DKKP/E ratio
–Dividend Yield
–Current Year
+342 733 975 DKK
Last Year
+103 969 611 DKK
Current Quarter
+34 125 621 DKK
Last Quarter
+15 086 622 DKK
Current Year
+323 562 993 DKK
Last Year
+103 969 611 DKK
Current Quarter
+24 638 119 DKK
Last Quarter
+10 490 348 DKK
Key Figures ZEAL
1 year
3 years
5 years
10 years
EBITDA
-713 092 586 DKK
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-7.38 %
PEG Ratio
0.31
Return On Equity TTM
-12.8 %
Wall Street Target Price
6 584.61 DKK
Revenue TTM
367 914 004 DKK
Book Value
132.46 DKK
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
228 %
Dividend Yield
–
Gross Profit TTM
103 969 611 DKK
Earnings per share
-11.16 DKK
Diluted Eps TTM
-11.16 DKK
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-193.49 %
Dividend Analytics ZEAL
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ZEAL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation ZEAL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
140.6421
Price Sales TTM
163.8578
Enterprise Value EBITDA
-53.4149
Price Book MRQ
6.417
Financials ZEAL
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ZEAL
For 52 weeks
271.76 DKK
971.85 DKK
50 Day MA
895.27 DKK
Shares Short Prior Month
–
200 Day MA
632.23 DKK
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart